Cite
HARVARD Citation
Amengual, J. et al. (n.d.). A PHASE 1 STUDY OF PRALATREXATE PLUS ROMIDEPSIN REVEALS MARKED ACTIVITY IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) PERIPHERAL T‐CELL LYMPHOMA (PTCL). Hematological oncology. pp. 87-88. [Online].